Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 10, Number 6—June 2004
Research

Nursing Home Residents and Enterobacteriaceae Resistant to Third-Generation Cephalosporins

Carolyn Sandoval*, Stephen D. Walter*, Allison McGeer†, Andrew E. Simor†, Suzanne F. Bradley‡, Lorraine M. Moss*, and Mark B. Loeb*Comments to Author 
Author affiliations: *McMaster University, Hamilton, Ontario, Canada; †Mount Sinai Hospital, Toronto, Ontario, Canada; ‡Sunnybrook and Women’s College Health Science Centre, Toronto, Ontario, Canada; ‡Veterans’ Affairs Health Systems, and University of Michigan Medical School, Ann Arbor, Michigan, USA

Main Article

Table 3

Univariate logistic regression analyses of individual-level variables with clinical isolate of Enterobacteriaceae resistant to third-generation cephalosporins as the dependent variable

Variablesa Case-patients (%) Controls (%) OR (95% CI)b p value
Any antimicrobial drug
 13 (48)
 27 (32)
 2.0 (0.8 to 4.8)
 0.125
Any cephalosporin
 8 (30)
 6 (7)
 5.5 (0.1 to 0.6)
 0.004
Third-generation cephalosporin
 2 (7)
 2 (2)
 3.3 (0.04 to 2.2)
 0.242
Fluoroquinolone
 3 (11)
 7 (8)
 1.4 (0.1 to 3.0)
 0.649
Trimethoprim/sulfamethoxazole 4 (15) 5 (6) 2.8 (0.1 to 1.4) 0.150

a10 weeks before date of confirmed Enterobacteriaceae infection.
bOR, odds ratio; CI, confidence interval.

Main Article

Page created: February 22, 2011
Page updated: February 22, 2011
Page reviewed: February 22, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external